Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Overweight × Naltrexone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Breast Neoplasms 2 Substance Withdrawal Syndrome 1 Prostatic Neoplasms 1 Overweight 1 Obesity 1 Melanoma 1 Kidney Neoplasms 1 Glioma 1 Glioblastoma 1 Chronic Pain 1 Carcinoma, Lobular 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1

Interventions

sultamicillin 1 licogliflozin 1 drospirenone and ethinyl estradiol combination 1 drospirenone 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Sugars 1 Naltrexone 1 Flutamide 1 Exenatide 1 Ethinyl Estradiol 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04499950 2025-03-06

A-NEW

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed

53 enrolled 14 charts

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡